Modulation of tramadol release from a hydrophobic matrix: Implications of formulations and processing variables

AAPS PharmSciTech

Volumn 11, Issue 1, 2010, Pages 433-440

  Sudha, B S ^a   Sridhar, B K ^a   Srinatha, A ^a  

^a NATIONAL COLLEGE OF PHARMACY   (India)

Author keywords

Diffusion; Hydrogenated cottonseed oil; Matrix tablet; Sustained release; Tramadol

Indexed keywords

CARBOXYMETHYLCELLULOSE; COTTON SEED OIL; DODECYL SULFATE SODIUM; HYDROXYPROPYLMETHYLCELLULOSE; MACROGOL 4000; POLYSORBATE 20; THEOPHYLLINE; TRAMADOL; WAX;

ARTICLE; CHEMICAL REACTION KINETICS; CONTROLLED STUDY; DRUG DIFFUSION; DRUG SOLUBILITY; HEAT TREATMENT; HYDROPHOBICITY; MODULATION; PRIORITY JOURNAL; PROCESSING; SUSTAINED DRUG RELEASE; SUSTAINED RELEASE FORMULATION; TABLET COMPRESSION; TABLET DISINTEGRATION; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TABLET MATRIX; WEIGHT;

CHEMISTRY, PHARMACEUTICAL; DOSAGE FORMS; EXCIPIENTS; HYDROPHOBICITY; METHYLCELLULOSE; PHARMACEUTICAL PREPARATIONS; POLYETHYLENE GLYCOLS; SURFACE-ACTIVE AGENTS; TABLETS; TRAMADOL; WAXES;

EID: 77950880581     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-010-9400-5     Document Type: Article

References (25)

1. FQ Li JH Hu JX Deng 2006 In vitro controlled release of sodium ferulate from Compritol 888 ATO-based matrix tablets Int J Pharm. 324 152 157 10.1016/j.ijpharm.2006.06.006 1:CAS:528:DC%2BD28XhtVOgu7%2FN 16837152 (Pubitemid 44528916)
2. Tiwari SB, Murthy TK, Pai MR, Mehta PR. Controlled release formulation of tramadol hydrochloride using hydrophilic and hydrophobic matrix system. AAPS PharmSciTech. 2003;4(3):Article 31.
3. LG Martini M Coles K Gravell S Stephenson 2000 The use of hydrophobic matrix for the sustained release of a highly water soluble drug Drug Dev Ind Pharm. 26 79 83 10.1081/DDC-100100330 1:CAS:528:DC%2BD3cXhtVSqtrk%3D 10677813 (Pubitemid 30075305)
4. V Jannin E Pochard O Chambin 2006 Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5 Int J Pharm. 309 6 15 10.1016/j.ijpharm.2005.10.042 1:CAS:528:DC%2BD28XnvVWnug%3D%3D 16376034 (Pubitemid 43129459)
5. YE Zhang JB Schwartz 2000 Effect of diluents on tablet integrity and controlled drug release Drug Dev Ind Pharm. 26 761 765 10.1081/DDC-100101295 1:CAS:528:DC%2BD3cXkt1ehsLw%3D 10872095 (Pubitemid 30397331)
6. YE Zhang JB Schwartz 2003 Melt granulation and heat treatment for wax matrix-controlled drug release Drug Dev Ind Pharm. 29 131 138 10.1081/DDC-120016720 1:CAS:528:DC%2BD3sXhvF2isr8%3D 12648009 (Pubitemid 36292936)
7. S Cheboyina CM Wyandt 2008 Wax- based sustained release matrix pellets prepared by a novel freeze pelletization technique I. Formulation and process variables affecting pellet characteristics Int J Pharm. 359 158 166 10.1016/j.ijpharm.2008.04.011 1:CAS:528:DC%2BD1cXmvVenu7g%3D 18499369
8. S Cheboyina CM Wyandt 2008 Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms Int J Pharm. 359 167 173 10.1016/j.ijpharm.2008. 04.001 1:CAS:528:DC%2BD1cXmvVenu7k%3D 18495391
9. ® as lipophilic glycerides used for the preparation of controlled release matrix pellets Int J Pharm. 260 47 57 10.1016/S0378-5173(03)00229-1 1:CAS:528:DC%2BD3sXksFKrt70%3D 12818809 (Pubitemid 36724860)
10. ® matrix. Effect of mannitol and hydroxypropyl methyl cellulose on the release of theophylline Drug Dev Ind Pharm. 12 1309 1327 10.3109/03639048609065861 1:CAS:528:DyaL28XltVanurc%3D
11. ES Ghali GH Klinger JB Schwartz 1989 Thermal treatment of beads with wax for controlled release Drug Dev Ind Pharm. 15 1311 1328 10.3109/ 03639048909062747 1:CAS:528:DyaL1MXlsVSnsrw%3D
12. Rowe CR, Sheskey PJ, Owen SC. Handbook of pharmaceutical excipient. London: Pharmaceutical press; 2006.
13. Amaral MH, Lobo JMS, Ferreira DC. Effect of hydroxypropyl methyl cellulose and hydrogenated castor oil on naproxen release from sustained release tablets. AAPS PharmSciTech. 2001;2(2):Article 6.
14. O'Neil MJ, Smith A, Heckelman PE. The Merck index. New Jersey: Merck research laboratories; 2001.
15. Sweetman SC. Martindale-the complete drug reference. London: Pharmaceutical press; 2002.
16. ® to prepare sustained release tablets of theophylline and quinidine gluconate Drug Dev Ind Pharm. 16 1963 1969 10.3109/03639049009023634
17. T Higuchi 1963 Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices J Pharm Sci. 52 1145 1149 10.1002/jps.2600521210 1:CAS:528:DyaF2cXlt1Whsg%3D%3D 14088963
18. RW Korsmeyer R Gurny EM Doelker P Buri NA Peppas 1983 Mechanism of solute release from porous hydrophilic polymers Int J Pharm. 15 25 35 10.1016/0378-5173(83)90064-9 1:CAS:528:DyaL3sXksVens7Y%3D (Pubitemid 13092121)
19. F Langenbucher 1972 Linearization of dissolution rate curves by Weibull distribution J Pharm Pharmcol. 24 979 981 1:CAS:528:DyaE3sXmt1Wgsg%3D%3D
20. YE Zhang R Tchao JB Schwartz 2001 Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release Pharm Dev Tech. 6 131 144 10.1081/PDT-100000736 1:CAS:528:DC%2BD3MXksVGntL4%3D (Pubitemid 32532018)
21. J Hamdani AJ Moes K Amighi 2002 Development and evaluation of prolonged release pellets obtained by melt pelletization process Int J Pharm. 245 67 177 10.1016/S0378-5173(02)00348-4 (Pubitemid 35299902)
22. C Bossard V Ratismbazafy DL Yiouses 1991 Modeling of theophylline compounds release from hard gelatin capsules containing gelucire matrix granules Drug Dev Ind Pharm. 17 1267 1277 10.3109/03639049109057296
23. AH Kamel MS Sokar VF Naggar SS Gamal 2002 Bioadhesive controlled release metronidazole vaginal tablets Acta Pharm. 52 171 179
24. Doelker E. Swelling behavior of water-soluble cellulose derivatives. In: Brannon PL, Harland RS, editors. Absorbent polymer technology. Amsterdam: Elsevier; 1990. p. 125-45.
25. C Kim 1995 Drug release from compressed hydrophilic POLYOX-WSR tablets J Pharmacol Sci. 84 303 306 10.1002/jps.2600840308 1:CAS:528:DyaK2MXjvVSkt7s%3D